查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590821

基因型鑒定市場：按產品、技術和應用分類 - 2025-2030 年全球預測

Genotyping Market by Product (Instruments & Services, Reagents & Kits), Technology (Capillary Electrophoresis, Mass Spectrometry, Microarray), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年基因型鑒定市值為207.1億美元，預計到2024年將達到236.3億美元，複合年成長率為14.14%，到2030年將達到522.9億美元。

基因型鑒定包括透過檢查個體的 DNA 序列來確定基因組成差異的過程。這對於個人化醫療、藥物基因組學、生物技術和農業生物學等多種應用至關重要。對精準醫療日益成長的需求推動了基因型鑒定的需求，精準醫療根據個人的基因組成提供量身定做的醫療保健解決方案。在農業中，它有助於制定提高產量和抗病能力的作物改良計劃。 KEYWORD市場價值鏈從生物醫學研究中心和醫院延伸到農業機構和生物技術公司。市場成長主要是由於基因組技術的進步、DNA定序成本的下降以及遺傳疾病數量的增加推動了早期診斷和介入的需求。此外，人們對降低醫療保健成本的日益關注正在推動疾病預防和控制的基因型鑒定解決方案的發展。然而，諸如對遺傳資料隱私的倫理擔憂以及先進基因型鑒定技術的高成本等挑戰減緩了市場滲透率。一個主要的成長機會在於整合人工智慧進行實質資料解釋，這可以顯著提高醫療保健領域的診斷準確性和預測模型。投資攜帶式且負擔得起的基因型鑒定套件，特別是對於低收入地區，代表著巨大的業務成長潛力。此外，高科技公司和學術研究中心之間的合作可以帶來增強即時基因型鑒定能力的創新解決方案。然而，監管障礙和遵守嚴格的遺傳資訊法仍然是必須解決的障礙。促進基因組資料的開放獲取，同時確保強力的隱私措施，可以為研究和開發開闢新的途徑。因此，徹底解決監管和倫理問題以及技術創新可以將基因型鑒定市場推向更高的高度，並滿足不斷成長的社會和工業需求。

主要市場統計
基準年[2023] 207.1億美元
預測年份 [2024] 236.3億美元
預測年份 [2030] 522.9億美元
複合年成長率（%） 14.14%

市場動態：揭示快速發展的基因型鑒定市場的關鍵市場洞察

供需的動態交互作用正在改變基因型鑒定市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 基因型鑒定在藥物發現和藥物開發中的重要性日益增加
    • 帕金森氏症和透納氏症遺傳疾病的盛行率增加
    • 資料分析中生物資訊解決方案的潛在需求
  • 市場限制因素
    • 相對昂貴的設備
  • 市場機會
    • 定序計劃在世界各地的重要性日益增加
    • 農業領域的持續需求
  • 市場挑戰
    • 缺乏訓練有素的專業人員以及對基因型鑒定資料管理的擔憂

波特五力：駕馭基因型鑒定市場的策略工具

波特的五力架構是了解基因型鑒定市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因型鑒定市場的外部影響

外部宏觀環境因素在塑造基因型鑒定市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因型鑒定市場的競爭格局

對基因型鑒定市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因型鑒定市場供應商績效評估

FPNV 定位矩陣是評估基因型鑒定市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製基因型鑒定市場的成功之路

基因型鑒定市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 基因型鑒定在藥物發現與開發中日益重要
      • 帕金森氏症和透納氏症遺傳性疾病的增加
      • 資料分析中生物資訊解決方案的潛在需求
    • 抑制因素
      • 相對昂貴的設備
    • 機會
      • 全球定序計劃的重要性日益增加
      • 農業產業持續需求
    • 任務
      • 缺乏訓練有素的專業人員以及對基因型鑒定資料管理的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章基因型鑒定市場：依產品

  • 設備和服務
  • 試劑和套件

第7章基因型鑒定市場：依技術分類

  • 毛細管電泳
  • 質譜分析
  • 微陣列
  • PCR
  • 定序

第8章基因型鑒定市場：依應用分類

  • 診斷
  • 藥物發現

第 9 章美洲基因型鑒定市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太基因基因型鑒定市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的基因型鑒定市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agena Bioscience, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Biofortuna Limited
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Precision Biomarker Resources, Inc.
  • Qiagen NV
  • Roche Diagnostics Corporation
  • Sigma-Aldrich Corporation
  • ThermoFisher Scientific, Inc.
Product Code: MRR-A77F2EE7AB77

The Genotyping Market was valued at USD 20.71 billion in 2023, expected to reach USD 23.63 billion in 2024, and is projected to grow at a CAGR of 14.14%, to USD 52.29 billion by 2030.

Genotyping encompasses the process of determining differences in the genetic makeup by examining the individual's DNA sequence. It is crucial for various applications such as personalized medicine, pharmacogenomics, biotechnology, and agricultural biology. The necessity of genotyping stems from the increasing demand for precision medicine which caters to tailored healthcare solutions based on individual genetic makeups. In the agricultural sector, it helps devise crop improvement programs to enhance yield and disease resistance. The value chain of genotyping market extends from biomedical research centers and hospitals to agricultural institutes and biotechnology companies. Market growth is influenced significantly by advancements in genomic technologies, decreasing costs of DNA sequencing, and an increase in genetic diseases spurring demand for early diagnosis and intervention. Additionally, the growing focus on reducing healthcare costs fuels genotyping solutions in disease prevention and management. However, challenges such as ethical concerns regarding genetic data privacy and the high cost of advanced genotyping technologies slow down market penetration. Key growth opportunities exist in the areas of integrating artificial intelligence for substantial data interpretation, which can greatly enhance diagnostic accuracy and prediction models in healthcare. Investment in portable and affordable genotyping kits, especially for low-income regions, presents significant business growth potential. Moreover, collaborations between tech companies and academic research centers can yield innovative solutions enhancing real-time genotyping capabilities. Nevertheless, regulatory hurdles and compliance with stringent genetic information laws remain deterrents that need addressing. Fostering open access to genomic data while ensuring robust privacy measures could unlock new avenues of research and development. Therefore, a thorough approach towards resolving regulatory and ethical concerns along with technological innovation can propel the genotyping market to significant heights, aligning it with growing societal and industry-specific demands.

KEY MARKET STATISTICS
Base Year [2023] USD 20.71 billion
Estimated Year [2024] USD 23.63 billion
Forecast Year [2030] USD 52.29 billion
CAGR (%) 14.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genotyping Market

The Genotyping Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing significance of genotyping in drug discovery and development
    • Growing prevalence of genetic diseases such as Parkinson's, turner syndrome
    • Potential demand for bioinformatics solutions in data analysis
  • Market Restraints
    • Relatively expensive equipment
  • Market Opportunities
    • Emerging importance of sequencing projects globally
    • Ongoing demand in agriculture industries
  • Market Challenges
    • Lack of trained professional and concerns in data management in genotyping

Porter's Five Forces: A Strategic Tool for Navigating the Genotyping Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genotyping Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genotyping Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genotyping Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genotyping Market

A detailed market share analysis in the Genotyping Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genotyping Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genotyping Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genotyping Market

A strategic analysis of the Genotyping Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genotyping Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Biofortuna Limited, Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., Precision Biomarker Resources, Inc., Qiagen NV, Roche Diagnostics Corporation, Sigma-Aldrich Corporation, and ThermoFisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Genotyping Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments & Services and Reagents & Kits.
  • Based on Technology, market is studied across Capillary Electrophoresis, Mass Spectrometry, Microarray, PCR, and Sequencing.
  • Based on Application, market is studied across Diagnostics and Drug Discovery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing significance of genotyping in drug discovery and development
      • 5.1.1.2. Growing prevalence of genetic diseases such as Parkinson's, turner syndrome
      • 5.1.1.3. Potential demand for bioinformatics solutions in data analysis
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively expensive equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging importance of sequencing projects globally
      • 5.1.3.2. Ongoing demand in agriculture industries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of trained professional and concerns in data management in genotyping
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genotyping Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments & Services
  • 6.3. Reagents & Kits

7. Genotyping Market, by Technology

  • 7.1. Introduction
  • 7.2. Capillary Electrophoresis
  • 7.3. Mass Spectrometry
  • 7.4. Microarray
  • 7.5. PCR
  • 7.6. Sequencing

8. Genotyping Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery

9. Americas Genotyping Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Genotyping Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Genotyping Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agena Bioscience, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories Inc.
  • 4. Biofortuna Limited
  • 5. Danaher Corporation
  • 6. Eurofins Scientific SE
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Illumina, Inc.
  • 9. Merck KGaA
  • 10. PerkinElmer, Inc.
  • 11. Precision Biomarker Resources, Inc.
  • 12. Qiagen NV
  • 13. Roche Diagnostics Corporation
  • 14. Sigma-Aldrich Corporation
  • 15. ThermoFisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GENOTYPING MARKET RESEARCH PROCESS
  • FIGURE 2. GENOTYPING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOTYPING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOTYPING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOTYPING MARKET SIZE, BY INSTRUMENTS & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOTYPING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOTYPING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOTYPING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOTYPING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOTYPING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOTYPING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2023